Aldeyra Therapeutics, Inc.
ALDX
$1.71
-$0.05-2.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.45M | -6.46M | -7.69M | -9.77M | -9.93M |
| Total Depreciation and Amortization | 66.60K | 65.10K | 63.70K | 62.30K | 60.90K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 267.30K |
| Total Other Non-Cash Items | -937.20K | 1.10M | 2.36M | -182.40K | 1.88M |
| Change in Net Operating Assets | -786.90K | 700.00 | -1.76M | 1.33M | -4.75M |
| Cash from Operations | -5.11M | -5.30M | -7.02M | -8.56M | -12.47M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 16.00M | 25.00M | -554.10K | 7.29M |
| Cash from Investing | -- | 16.00M | 25.00M | -554.10K | 7.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 71.10K | 0.00 | 120.70K | 0.00 | 1.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 71.10K | 0.00 | 120.70K | 0.00 | 1.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.04M | 10.70M | 18.10M | -9.11M | -4.18M |